Logiscreen

Haemonetics Corp

$102.69
Market Cap 4.67B
ROE 11.3%
Gross Margin 59.8%
Debt/Equity 1.4
Current Ratio 3.1
Revenue QoQ 5.6%
EPS QoQ 0.0%
F-Score 7

About

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components.

Exchange
NYSE
Sector
Healthcare
Industry
Medical Instruments & Supplies

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
36.39
vs median 36.93
P/B
4.45
vs median 2.32
ROE
0.11
vs median 0.09

Decent quality with acceptable fundamentals

Mid-cap company with growth potential

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics